JunD mediates survival signaling by the JNK signal transduction pathway

Molecular Cell

Volumn 11, Issue 6, 2003, Pages 1479-1489

  Lamb, Jennifer A ^a   Ventura, Juan Jose ^a   Hess, Patricia ^a   Flavell, Richard A ^b   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STIMULATION;

ANIMALIA;

EID: 0038433303     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00203-X     Document Type: Article

References (52)

1. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11:2001;372-377.
2. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784.
3. Bossy-Wetzel E., Bakiri L., Yaniv M. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16:1997;1695-1709.
4. Brunet A., Datta S.R., Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11:2001;297-305.
5. Chen G., Goeddel D.V. TNF-R1 signaling. a beautiful pathway Science. 296:2002;1634-1635.
6. Chen Y.R., Wang X., Templeton D., Davis R.J., Tan T.H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:1996;31929-31936.
7. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA. 94:1997;10057-10062.
8. Davis R.J. The JNK signal transduction pathway. Cell. 103:2000;239-252.
9. de Groot R.P., Karperien M., Pals C., Kruijer W. Characterization of the mouse junD promoter-high basal level activity due to an octamer motif. EMBO J. 10:1991;2523-2532.
10. Deng T., Karin M. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7:1993;479-490.
11. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., Cong R., Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature. 414:2001;308-313.
12. Devin A., Cook A., Lin Y., Rodriguez Y., Kelliher M., Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1. TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation Immunity. 12:2000;419-429.
13. Ganiatsas S., Kwee L., Fujiwara Y., Perkins A., Ikeda T., Labow M.A., Zon L.I. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA. 95:1998;6881-6886.
14. Guo Y.L., Baysal K., Kang B., Yang L.J., Williamson J.R. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273:1998;4027-4034.
15. Ham J., Babij C., Whitfield J., Pfarr C.M., Lallemand D., Yaniv M., Rubin L.L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939.
16. Hess P., Pihan G., Sawyers C.L., Flavell R.A., Davis R.J. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32:2002;201-205.
17. Hong S.Y., Yoon W.H., Park J.H., Kang S.G., Ahn J.H., Lee T.H. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J. Biol. Chem. 275:2000;18022-18028.
18. Jochum W., Passegue E., Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene. 20:2001;2401-2412.
19. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity. 8:1998;297-303.
20. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 22:1999;667-676.
21. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
22. Lee S.Y., Reichlin A., Santana A., Sokol K.A., Nussenzweig M.C., Choi Y. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity. 7:1997;703-713.
23. Lei K., Nimnual A., Zong W.X., Kennedy N.J., Flavell R.A., Thompson C.B., Bar-Sagi D., Davis R.J. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol. Cell. Biol. 22:2002;4929-4942.
24. Liu Z.G., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions. JNK activation is not linked to apoptosis while NF-κB activation prevents cell death Cell. 87:1996;565-576.
25. Natoli G., Costanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 275:1997;200-203.
26. Nishina H., Vaz C., Billia P., Nghiem M., Sasaki T., De la Pompa J.L., Furlonger K., Paige C., Hui C., Fischer K.D.et al. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development. 126:1999;505-516.
27. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
28. Potapova O., Gorospe M., Dougherty R.H., Dean N.M., Gaarde W.A., Holbrook N.J. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner. Mol. Cell. Biol. 20:2000;1713-1722.
29. Rahmani M., Peron P., Weitzman J., Bakiri L., Lardeux B., Bernuau D. Functional cooperation between JunD and NF-kappaB in rat hepatocytes. Oncogene. 20:2001;5132-5142.
30. Reuther-Madrid J.Y., Kashatus D., Chen S., Westwick J., Davis R.J., Earp H.S., Wang C.-Y., Baldwin A.S. Jr. The p65/RelA subunit of NF-κB suppresses sustained and anti-apoptotic JNK activity induced by TNF. Mol. Cell. Biol. 22:2002;8175-8183.
31. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
32. Roulston A., Reinhard C., Amiri P., Williams L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273:1998;10232-10239.
33. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89:1999;115-124.
34. Sluss H.K., Barrett T., Derijard B., Davis R.J. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14:1994;8376-8384.
35. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R., Lipp J. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha- induced apoptosis. J. Exp. Med. 188:1998;211-216.
36. Tada K., Okazaki T., Sakon S., Kobarai T., Kurosawa K., Yamaoka S., Hashimoto H., Mak T.W., Yagita H., Okumura K.et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J. Biol. Chem. 276:2001;36530-36534.
37. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature. 414:2001;313-317.
38. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 288:2000;870-874.
39. Traverse S., Seedorf K., Paterson H., Marshall C.J., Cohen P., Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4:1994;694-701.
40. Uren A.G., Pakusch M., Hawkins C.J., Puls K.L., Vaux D.L. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA. 93:1996;4974-4978.
41. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:1996;787-789.
42. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O.et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:1998;267-276.
43. 2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23:2003;2871-2882.
44. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis. potentiation by inhibition of NF-kappaB Science. 274:1996;784-787.
45. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-kappaB antiapoptosis. induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation Science. 281:1998;1680-1683.
46. Wang C.Y., Guttridge D.C., Mayo M.W., Baldwin A.S. Jr. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:1999;5923-5929.
47. Weitzman J.B., Fiette L., Matsuo K., Yaniv M. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell. 6:2000;1109-1119.
48. Wu M.X., Ao Z., Prasad K.V., Wu R., Schlossman S.F. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science. 281:1998;998-1001.
49. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
50. Yang D., Tournier C., Wysk M., Lu H.T., Xu J., Davis R.J., Flavell R.A. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA. 94:1997;3004-3009.
51. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N.et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
52. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., Ng M., Wakeham A., Khoo W., Mitchell K.et al. Fadd. essential for embryo development and signaling from some, but not all, inducers of apoptosis Science. 279:1998;1954-1958.